Stock Market Reviews

ZLAB (Zai Lab Limited) News

Get the latest news, insights, and market updates on ZLAB (Zai Lab Limited). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Zai Lab Announces Oral Presentation of Updated Data from Global Phase 1 Trial of Zocilurtatug Pelitecan (ZL-1310), a Potential First-in-Class DLL3-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
  SHANGHAI & CAMBRIDGE, Mass., October 13, 2025--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that a late-breaking abstract (LBA) featuring new data from its global Phase 1 clinical trial (NCT06179069) evaluating zocilurtatug pelitecan (zoci), formerly known as ZL-1310, has been selected for an oral presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place October 22-26, 2025, in Boston, Massachusetts. The presentation will
  Oct 13, 2025 - $ZLAB
• Zai Lab Limited (ZLAB): A Bull Case Theory
  We came across a bullish thesis on Zai Lab Limited on Value investing subreddit by mrmrmrj. In this article, we will summarize the bulls’ thesis on ZLAB. Zai Lab Limited’s share was trading at $30.00 as of September 4th. Zai Lab (ZLAB), a $3.3B market cap Chinese pharmaceutical company, is growing revenues at 40%+ and positioned to […]
  Sep 16, 2025 - $ZLAB
• Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
  Asian equities traded in the US as American depositary receipts were tracking higher Wednesday morni
  Sep 10, 2025 - $ZLAB
• China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order
  Biotech stocks Zai Labs and BeOne Medicines plummeted Wednesday on reports President Donald Trump will issue an executive order to reduce U.S. access to drugs developed in China.
  Sep 10, 2025 - $ZLAB
• Institutional investors may overlook Zai Lab Limited's (NASDAQ:ZLAB) recent US$260m market cap drop as long-term gains remain positive
  Key Insights Given the large stake in the stock by institutions, Zai Lab's stock price might be vulnerable to their...
  Sep 6, 2025 - $ZLAB
• Asian Equities Traded in the US as American Depositary Receipts Decline Slightly in Thursday Trading
  Asian equities traded in the US as American depositary receipts were tracking lower Thursday morning
  Sep 4, 2025 - $ZLAB
• Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong
  SHANGHAI & CAMBRIDGE, Mass., September 02, 2025--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the Hong Kong Department of Health has approved TIVDAK (tisotumab vedotin-tftv) in Hong Kong for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.
  Sep 2, 2025 - $ZLAB
• Zai Lab Announces Participation in Investor Conferences in September 2025
  SHANGHAI & CAMBRIDGE, Mass., August 28, 2025--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in September 2025:
  Aug 28, 2025 - $ZLAB